Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
IHC shares rose strongly from start of trading today. I presume another 'Share Tip', if so from what source? Otherwise likely reason for the renewed buying interest?
Hi, this has been highly recommended by Simon Thompson of investors chronicle
SP dropping like a stone, anyone know why?
There has been systematic share dumping by someone. 10k every 15 secs for approx 120,000 shares. Not sure why but to me that's why the sp has tanked.
It’s probably Premier Milton reducing their massive holding again. If you look back over the last 6 months the share price is very volatile. I think this is an excellent company and so I’ve taken the opportunity to increase my holdings.
Great news on the Egyptian order. Good news was completely diluted by the russian vs ukraine affair.
Reasonably priced at current levels.
TU expected very shortly. Should be a positive one. Hopefully a positive thumbs up by Simon T as well would be nice too.
Simon T
13/10/21
First-half adjusted operating profit up 22 per cent to £2.6m on 47 per cent higher revenue of £20.9m
Analysts upgrade full-year operating profit forecasts by 12 per cent to £3.5m
Integration of SLE acquisition almost complete
Crawley-based Inspiration Healthcare (IHC:123p), a fully integrated medical technology company with a strong focus on the high-growth neonatal intensive care market, has prompted analysts to upgrade their earnings estimates yet again. Last summer’s acquisition of SLE, a designer and maker of ventilators for neonatal intensive care, has been the driver.
That’s because SLE has not only enlarged the group’s global distribution network – 90 per cent of SLE’s sales are export orders with a strong focus on China, Japan, India and the Middle East – but is creating cross-selling opportunities, too. For example, by bundling consumable breathing circuits with the sale of SLE’s ventilators, and expanding market penetration into a larger installed ventilator and consumable customer base, Inspiration can introduce its breathing circuits to new customers who have been using rival products. In the six months to 31 July 2021, the group won an order worth £350,000 for its own brand Viomedex circuits from an SLE distributor in the Middle East.
Inspiration also received regulatory approval in Japan and China for its enhanced top-of-the-range SLE6000 neonatal ventilator that includes features such as enhanced High Frequency Oscillatory Ventilation (designed for use with critically ill infants) and the OxyGenie ® patented oxygen control algorithm (helps maintain infants at their targeted oxygen saturation levels). This led to a significant number of new orders in both countries, and has raised the profile of the group’s neonatal ventilator portfolio internationally.
In the UK, Inspiration’s AlphaCore patient warming system is proving very popular – sales more than doubled year on year – for the prevention of inadvertent hypothermia in neonatal, paediatric and perioperative environments. The benefits of warming are undeniable, such as improved morbidity and mortality, lower infection rates, reduced blood loss and less time in recovery.
The greater focus on higher-margin branded products – 55 per cent of the sales mix, up from 20 per cent in the first half of 2020 – is helping to drive up gross margin (from 41.4 per cent to 52.5 per cent) despite input cost pressures, which are being managed well. The combination of strong organic growth, a robust order book and increased demand across the entire group led to 12 per cent operating profit upgrades for the full year.
Cont'd
Simon T
13/10/21
True, annual cash profits are expected to be flat at £5.6m on revenue of £40.6m year on year, but the prior year’s result included £7.3m of one-off Covid-19 related ventilator orders. Strip these out, and house broker Cenkos Securities pencils in 7 per cent revenue growth in the second half, a healthy underlying trend that is not yet fully priced in an enterprise valuation of £75m, or 13.4 times cash profits, after factoring in net cash of £8.6m (12.6p a share). That’s a hefty ratings discount to neonatal medtech peers, Natus Medical (41 times) and Fisher & Paykel Healthcare (23 times).
Despite the prior year having a one-off rise of £7.3mn, due to covid related revenue, this year they really knocked the ball out of the park.
Excellent performance by the company.
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that, following the close of the financial year, the Group is expecting to exceed market expectations and to report Group revenues for the financial year ended 31 January 2022 of approximately £41.0 million representing an increase of 10.9% compared to the prior financial year. Adjusted EBITDA* is expected to be not less than £6.2 million, representing growth of 10.5% over the prior financial year, which includes a one-off receipt of £0.2 million. Operating profit is similarly ahead of market expectations.